Learn More
Invitrogen™ Human CHEK1 (CHK1), His Tag Recombinant Protein
Recombinant Protein
708.00€ - 8550.00€
Especificaciones
Número de acceso | O14757 |
---|---|
Concentración | See Label |
Para utilizar con (aplicación) | Kinase Assay |
Formulación | 50 mM tris with 0.05% NP-40, 0.05 mM EDTA, 1 mM DTT, 250 mM NaCl, 50% glycerol and no preservative; pH 7.5 |
ID de gen (Entrez) | 1111 |
Código de producto | Marca | Cantidad | Precio | Cantidad y disponibilidad | |||||
---|---|---|---|---|---|---|---|---|---|
Código de producto | Marca | Cantidad | Precio | Cantidad y disponibilidad | |||||
11509286
|
Invitrogen™
P3040 |
10 μg |
708.00€
10 microgramos |
Por favor, inicie sesión para comprar este producto. ¿No tiene usuario web? Regístrese hoy mismo. | |||||
10583093
|
Invitrogen™
PV3982 |
1 mg |
8550.00€
1 miligramo |
Por favor, inicie sesión para comprar este producto. ¿No tiene usuario web? Regístrese hoy mismo. | |||||
Descripción
For maximum recovery please spin prior to use. Unless noted below, aliquots of the 5 μg, 10 μg and 20 μg sizes of kinase are not recommended as materials can be used in original packaging until exhausted. For larger sizes, the number of freeze/thaws may be reduced by preparing aliquots, aliquots below 20 μL are not recommended. Please never store a kinase diluted. If properly stored at -80C, this product is guaranteed for 6 months from date of purchase. Protein Form: Full Length
CHEK1 (CHK1) is a serine/threonine protein kinase involved in preventing replication when DNA integrity is compromised. CHK1 is a key mediator in the DNA damage-induced checkpoint network. CHK1 is an evolutionarily conserved protein kinase that functions to ensure genomic integrity upon genotoxic stress. When the G2 or S checkpoint is abrogated by the inhibition of CHK1, p53-deficient cancer cells undergo mitotic catastrophe and eventually apoptosis, whereas normal cells are still arrested in the G1 phase. Thus, CHK1 inhibitors can preferentially potentiate the efficacy of DNA damaging agents in cancer cells, and Chk1 is an attractive therapeutic target for cancer treatment, especially since approximately 50% of all human cancers are p53-deficient.Especificaciones
O14757 | |
Kinase Assay | |
1111 | |
Human CHEK1 (CHK1), His Tag | |
Chk1 | |
Unconjugated | |
Recombinant | |
Full length | |
Dry Ice | |
Liquid |
See Label | |
50 mM tris with 0.05% NP-40, 0.05 mM EDTA, 1 mM DTT, 250 mM NaCl, 50% glycerol and no preservative; pH 7.5 | |
58.1 kDa | |
C85740; Cell cycle checkpoint kinase; checkpoint kinase 1; checkpoint kinase 1 homolog; checkpoint kinase-1; Checkpoint, S. pombe, homolog of, 1; CHEK1; CHK1; CHK1 checkpoint homolog; Chk1-S; homolog of Chk1-S; HRD1 Protein; rad27; rad27 homolog; serine/threonine protein kinase CHK1; serine/threonine-protein kinase Chk1; Synoviolin; YBR1742; YBR274W | |
CAMKL Kinase Family | |
Human | |
His-tag | |
-80°C, Avoid Freeze/Thaw Cycles | |
Baculovirus |
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.